1. Complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis. (November 2022) Authors: Ploumen, R.; Claassens, E.; Kooreman, L.; Keymeulen, K.; van Kats, M.; Gommers, S.; Siesling, S.; van Nijnatten, T.; Smidt, M. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Diagnostic performance of noninvasive imaging for assessment of axillary pathologic complete response after neoadjuvant systemic therapy in clinically node-positive breast cancer: A systematic review and meta-analysis. (October 2020) Authors: Samiei, S.; de Mooij, C.; Lobbes, M.; Keymeulen, K.; van Nijnatten, T.; Smidt, M. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis. (November 2022) Authors: Ploumen, R.; de Mooij, C.M.; Gommers, S.; Keymeulen, K.; Smidt, M.; van Nijnatten, T. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗